Skip to Main Content

3rd Biennial Miami Precision Medicine

April 11-12, 2026
Ritz-Carlton - Fort Lauderdale

Woman doctor pointing at a DNA Helix

Join experts from Sylvester Comprehensive Cancer Center and leaders from prominent cancer institutions as they share insights and approaches to advance precision medicine into routine practice.

The event will feature two concurrent sessions:

  • Research Sessions Icon
    Provider Session - Advancing Precision Medicine:
    This session will focus on the integration of precision medicine into routine cancer care. Hear from national and international leaders about emerging innovations, clinical applications and the future of personalized oncology.
    Topics will include germline and genomic testing, multi-omics, molecular pathways, novel treatment and artificial intelligence.
  • Supportive Care Icon
    Patient Session - Empowering Survivors: Living Longer, Living Better:
    Designed for patients and advocates, this session will highlight role of germ line and genomic testing, principles of precision oncology and survivorship, role of clinical trials and more.
    Topics will include cancer prevention and treatment, lifestyle medicine and survivorship care.

Unlocking the Future of Healthcare:
Join Us at the Miami Precision Medicine Conference!

Join us at the 3rd Biannual Miami Precision Medicine Conference to immerse yourself in the latest advancements in precision oncology.
Learn from renowned experts and patient advocates, shaping the future of cancer care.

Objectives

At the conclusion of this activity, learners will be able to:

  • Expedite adoption of germline and genomic testing in clinical practice
  • Interpret next generation sequencing (NGS) results
  • Interpret results of a liquid biopsy (ctDNA)
  • Explain the role of multi-omics in precision oncology
  • Summarize role of biomarkers in selection of targeted therapies and immunotherapies in different cancer types
  • Recognize the emerging role of Artificial Intelligence in precision medicine
  • Describe common molecular alterations and the role of molecular diagnostic tests in different cancer types
  • Summarize recent and emerging data from key studies in clinical and translational cancer research
  • Implement strategies designed to improve the quality of cancer care, address barriers to optimal care and enhance the patient experience
  • Identify the role of lifestyle intervention in the precision medicine care model
  • Identify the role of scentific advances in the field of cancer biology and tumor pathogenesis
  • Develop collaborations that will lead to improved clinical trial portfolio and clinical trial participation
  • Interact with patients and patient advocacy groups to promote access to molecularly-driven therapies and available clinical trials
  • Facilitate patient-oncology experts' interaction and understanding of survivorship challenges in the era of precision medicine

Target Audience

Specialties

Family Medicine
General Surgery
Gynecology-Oncology
Hematology
Hospice and Palliative Medicine
Integrative Medicine
Internal Medicine
Neuro-Oncology
Neurosurgery
Obstetrics and Gynecology
Oncology
Pain Management
Pathology
Pediatric Oncology
Physical Medicine and Rehabilitation
Preventive Medicine
Radiation Oncology
Surgical Oncology
Thoracic Surgery
Transplant
Urologic Oncology

Professions

Allied Health Care Professional
Dietitian
Fellow
Medical Student
Nurse, Nurse Practitioner
Pharmacist
Physician
Physician Assistant
Researcher
Resident
Scientist
Technologist

Presented by:

Sylvester Comprehensive Cancer Center and NCI logos

Sponsored by:

University of Miami Miller School of Medicine